Figures & data
Table 1. Baseline characteristics.
Figure 1. Switching order. Name of biologic (and surgery) and number of patients. Patients are controlled in last step unless stated otherwise.
Figure 1. (Continued).
Expert Review of Clinical Immunology
Volume 19, 2023 - Issue 8: Chronic rhinosinusitis
Original Research
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making
, 
, , , , , , , , , , & show all
Rik van der Lansa Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-5361-6752View further author information
https://orcid.org/0000-0002-5361-6752View further author information, , , , , Matteo Boninie Department of Internal Medicine and Geriatrics, Catholic University of the Sacred Hearth, Rome, Italyhttps://orcid.org/0000-0001-9326-1370View further author information
https://orcid.org/0000-0001-9326-1370View further author information, , , , Ludger Klimekc Center for Rhinology and Allergology, Wiesbaden, Germanyhttps://orcid.org/0000-0002-2455-0192View further author information
https://orcid.org/0000-0002-2455-0192View further author information, & show all